Cassava Sciences Inc. [NASDAQ: SAVA] gained 5.73% on the last trading session, reaching $3.32 price per share at the time. The company report on September 11, 2020 that Cassava Sciences to Hold Conference Call on Monday, September 14, 2020 at 8:30 am ET.
Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, announced today that it will hold a conference call on Monday, September 14th at 8:30 a.m. Eastern Time.
The dial-in number for international callers is 1-212-231-2929. A replay of the webcast will remain available in the ‘Investors’ section of Cassava Sciences’ website, www.CassavaSciences.com, for 90 days following the conference. In addition, a telephonic replay of the call will be available until September 28, 2020. The replay dial-in numbers are 1-844-512-2921 for domestic callers and 1-412-317-6671 for international callers. Please use the replay conference ID number 21969265.
Cassava Sciences Inc. represents 24.78 million in outstanding shares, while the company has a total market value of $78.19 million with the latest information. SAVA stock price has been found in the range of $3.14 to $3.40.
If compared to the average trading volume of 1.73M shares, SAVA reached a trading volume of 2008960 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Cassava Sciences Inc. [SAVA]:
H.C. Wainwright have made an estimate for Cassava Sciences Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on May 18, 2020. The new note on the price target was released on May 15, 2020, representing the official price target for Cassava Sciences Inc. stock. Previously, the target price had yet another raise from $3 to $12, while Maxim Group kept a Buy rating on SAVA stock.
The Average True Range (ATR) for Cassava Sciences Inc. is set at 0.24 The Price to Book ratio for the last quarter was 3.39, with the Price to Cash per share for the same quarter was set at 1.07.
Trading performance analysis for SAVA stock
Cassava Sciences Inc. [SAVA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 9.57. With this latest performance, SAVA shares dropped by -1.19% in over the last four-week period, additionally sinking by -19.61% over the last 6 months – not to mention a rise of 171.95% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SAVA stock in for the last two-week period is set at 55.30, with the RSI for the last a single of trading hit 60.46, and the three-weeks RSI is set at 52.57 for Cassava Sciences Inc. [SAVA]. The present Moving Average for the last 50 days of trading for this stock 3.22, while it was recorded at 3.16 for the last single week of trading, and 4.60 for the last 200 days.
Cassava Sciences Inc. [SAVA]: A deeper dive into fundamental analysis
Return on Total Capital for SAVA is now -46.34, given the latest momentum, and Return on Invested Capital for the company is -22.20. Return on Equity for this stock declined to -22.20, with Return on Assets sitting at -21.23. When it comes to the capital structure of this company, Cassava Sciences Inc. [SAVA] has a Total Debt to Total Equity ratio set at 0.41. Additionally, SAVA Total Debt to Total Capital is recorded at 0.41, with Total Debt to Total Assets ending up at 0.38.
Reflecting on the efficiency of the workforce at the company, Cassava Sciences Inc. [SAVA] managed to generate an average of -$514,556 per employee.Cassava Sciences Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 19.40 and a Current Ratio set at 19.40.
Cassava Sciences Inc. [SAVA]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Cassava Sciences Inc. posted -0.06/share EPS, while the average EPS was predicted by analysts to be reported at -0.1/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 40.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SAVA.
An analysis of insider ownership at Cassava Sciences Inc. [SAVA]
There are presently around $20 million, or 25.20% of SAVA stock, in the hands of institutional investors. The top three institutional holders of SAVA stocks are: BLACKROCK INC. with ownership of 1,467,575, which is approximately 413.526% of the company’s market cap and around 10.47% of the total institutional ownership; VANGUARD GROUP INC, holding 1,121,210 shares of the stock with an approximate value of $3.72 million in SAVA stocks shares; and BLEICHROEDER LP, currently with $3.49 million in SAVA stock with ownership of nearly -39.61% of the company’s market capitalization.
Positions in Cassava Sciences Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 40 institutional holders increased their position in Cassava Sciences Inc. [NASDAQ:SAVA] by around 3,223,863 shares. Additionally, 19 investors decreased positions by around 3,246,411 shares, while 4 investors held positions by with 473,316 shares. The mentioned changes placed institutional holdings at 5,996,958 shares, according to the latest SEC report filing. SAVA stock had 23 new institutional investments in for a total of 835,137 shares, while 12 institutional investors sold positions of 2,031,278 shares during the same period.